Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$7.42 - $11.05 $5.1 Million - $7.6 Million
-687,500 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$14.52 - $22.46 $71,148 - $110,054
4,900 Added 0.72%
687,500 $9.98 Million
Q1 2021

May 17, 2021

BUY
$16.57 - $21.08 $72,908 - $92,751
4,400 Added 0.65%
682,600 $13.9 Million
Q4 2020

Feb 16, 2021

SELL
$14.89 - $20.16 $2.17 Million - $2.94 Million
-145,818 Reduced 17.7%
678,200 $12.1 Million
Q3 2020

Nov 16, 2020

SELL
$14.79 - $22.49 $62,118 - $94,458
-4,200 Reduced 0.51%
824,018 $12.2 Million
Q2 2020

Aug 14, 2020

BUY
$20.64 - $30.69 $1.61 Million - $2.4 Million
78,218 Added 10.43%
828,218 $17.4 Million
Q1 2020

May 15, 2020

BUY
$17.84 - $31.21 $1.69 Million - $2.96 Million
94,800 Added 14.47%
750,000 $17.3 Million
Q4 2019

Feb 14, 2020

BUY
$16.12 - $25.89 $1.7 Million - $2.72 Million
105,200 Added 19.13%
655,200 $17 Million
Q3 2018

Nov 14, 2018

SELL
$22.83 - $32.67 $2.34 Million - $3.35 Million
-102,600 Reduced 15.72%
550,000 $18 Million
Q4 2017

Feb 14, 2018

BUY
$25.82 - $35.66 $211,724 - $292,412
8,200 Added 1.27%
652,600 $18.2 Million
Q3 2017

Nov 14, 2017

BUY
$23.88 - $34.96 $15.4 Million - $22.5 Million
644,400
644,400 $22.1 Million

Others Institutions Holding TBPH

About Theravance Biopharma, Inc.


  • Ticker TBPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,782,400
  • Market Cap $640M
  • Description
  • Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...
More about TBPH
Track This Portfolio

Track Rock Springs Capital Management LP Portfolio

Follow Rock Springs Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Springs Capital Management LP with notifications on news.